MA Federal Judge Shoots Down Restriction on Prescribing Zohydro

Drug Industry Daily
A federal judge this week struck down Massachusetts’ recently enacted prescribing restrictions on Zogenix’s opioid painkiller Zohydro ER — restrictions that the drugmaker argued had effectively made the therapy unavailable and contravened the FDA’s right to approve drugs it considers safe and effective.

To View This Article:


Subscribe To Drug Industry Daily